Originally established as a division of the prestigious Danish Statens Serum Institut and currently held by Adelis Equity, SSID Group is a global leader in infectious disease clinical diagnostics and specializes in three segments: gastric, respiratory, and bloodborne diseases.
TECHLAB joined SSI Diagnostica Group in August 2022, providing customers worldwide with an even stronger portfolio of diagnostics.
